Ista Pharmaceuticals
Records under this name other than the patents Ista Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,736,841 | Bepotastine Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 9,517,220 | Bromfenac Bioavailability Formerly held In force · High confidence | In force | High confidence | |
| US 8,748,402 | Ophthalmic Formulations and Uses Thereof Formerly held Term ended Term ended Aug 5, 2025 · High confidence | Term ended | Term ended Aug 5, 2025 | High confidence |
| US 7,141,610 | Compositions and Methods for the Induction of Retinal Detachments Formerly held Term ended Term ended Dec 1, 2020 · Medium confidence | Term ended | Term ended Dec 1, 2020 | Medium confidence |
| US 6,039,943 | Method for accelerating clearance of hemorrhagic blood from the vitreous body with hyaluronidase Formerly held Term ended Term ended Aug 24, 2018 · From the USPTO record | Term ended | Term ended Aug 24, 2018 | From the USPTO record |
| US 6,161,544 | Methods for accelerated orthokeratology Formerly held Term ended Term ended Jan 28, 2018 · From the USPTO record | Term ended | Term ended Jan 28, 2018 | From the USPTO record |
| US 6,551,590 | Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood from the vireous body of the eye Formerly held Term ended Ended no later than Nov 22, 2015 · From the USPTO record | Term ended | Ended no later than Nov 22, 2015 | From the USPTO record |
| US 6,610,292 | Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders Formerly held Term ended Ended no later than Nov 22, 2015 · From the USPTO record | Term ended | Ended no later than Nov 22, 2015 | From the USPTO record |
| US 6,863,886 | Use of Hyaluronidase in the Manufacture of an Ophthalmic Preparation for Liquefying Vitreous Humor in the Treatment of Eye Disorders Formerly held Term ended Ended no later than Nov 22, 2015 · Low confidence | Term ended | Ended no later than Nov 22, 2015 | Low confidence |
| US 6,939,542 | Hyaluronidase Preparation for Ophtalmic Administration and Enzymatic Methods for Accelerating Clearance of Hemorrhagic Blood from the Vitreous Body of the Eye Formerly held Term ended Ended no later than Nov 22, 2015 · Low confidence | Term ended | Ended no later than Nov 22, 2015 | Low confidence |